Literature DB >> 17675189

Evaluation of fatty acid amides in the carrageenan-induced paw edema model.

Laura E Wise1, Roberta Cannavacciulo, Benjamin F Cravatt, Billy F Martin, Aron H Lichtman.   

Abstract

While it has long been recognized that Delta(9)-tetrahydrocannabinol (THC), the primary psychoactive constituent of cannabis, and other cannabinoid receptor agonists possess anti-inflammatory properties, their well known CNS effects have dampened enthusiasm for therapeutic development. On the other hand, genetic deletion of fatty acid amide hydrolase (FAAH), the enzyme responsible for degradation of fatty acid amides, including endogenous cannabinoid N-arachidonoyl ethanolamine (anandamide; AEA), N-palmitoyl ethanolamine (PEA), N-oleoyl ethanolamine (OEA), and oleamide, also elicits anti-edema, but does not produce any apparent cannabinoid effects. The purpose of the present study was to investigate whether exogenous administration of FAAs would augment the anti-inflammatory phenotype of FAAH (-/-) mice in the carrageenan model. Thus, we evaluated the effects of the FAAs AEA, PEA, OEA, and oleamide in wild-type and FAAH (-/-) mice. For comparison, we evaluated the anti-edema effects of THC, dexamethasone (DEX), a synthetic glucocorticoid, diclofenac (DIC), a nonselective cyclooxygenase (COX) inhibitor, in both genotypes. A final study determined if tolerance to the anti-edema effects of PEA occurs after repeated dosing. PEA, THC, DEX, DIC elicited significant decreases in carrageenan-induced paw edema in wild-type mice. In contrast OEA produced a less reliable anti-edema effect than these other drugs, and AEA and oleamide failed to produce any significant decreases in paw edema. Moreover, none of the agents evaluated augmented the anti-edema phenotype of FAAH (-/-) mice, suggesting that maximal anti-edema effects had already been established. PEA was the most effective FAA in preventing paw edema and its effects did not undergo tolerance. While the present findings do not support a role for AEA in preventing carrageenan-induced edema, PEA administration and FAAH blockade elicited anti-edema effects of an equivalent magnitude as produced by THC, DEX, and DIC in this assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675189      PMCID: PMC2200792          DOI: 10.1016/j.neuropharm.2007.06.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  60 in total

1.  Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.

Authors:  Kazuhito Tsuboi; Yong-Xin Sun; Yasuo Okamoto; Nobukazu Araki; Takeharu Tonai; Natsuo Ueda
Journal:  J Biol Chem       Date:  2005-01-17       Impact factor: 5.157

2.  Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides?

Authors:  Josée Guindon; Jesse LoVerme; André De Léan; Daniele Piomelli; Pierre Beaulieu
Journal:  Eur J Pharmacol       Date:  2006-09-08       Impact factor: 4.432

3.  Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.

Authors:  I Fedorova; A Hashimoto; R A Fecik; M P Hedrick; L O Hanus; D L Boger; K C Rice; A S Basile
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

4.  Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.

Authors:  V Di Marzo; D Melck; P Orlando; T Bisogno; O Zagoory; M Bifulco; Z Vogel; L De Petrocellis
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

5.  Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.

Authors:  Roberto Russo; Jesse LoVerme; Giovanna La Rana; Giuseppe D'Agostino; Oscar Sasso; Antonio Calignano; Daniele Piomelli
Journal:  Eur J Pharmacol       Date:  2007-03-19       Impact factor: 4.432

6.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

7.  Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.

Authors:  Xiangbin Wang; Rosa Linda Miyares; Gerard P Ahern
Journal:  J Physiol       Date:  2005-02-03       Impact factor: 5.182

8.  N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.

Authors:  Kazuhito Tsuboi; Christine Hilligsmann; Séverine Vandevoorde; Didier M Lambert; Natsuo Ueda
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

9.  Functional disassociation of the central and peripheral fatty acid amide signaling systems.

Authors:  Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

10.  Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.

Authors:  Aline Quartilho; Heriberto P Mata; Mohab M Ibrahim; Todd W Vanderah; Frank Porreca; Alexandros Makriyannis; T Philip Malan
Journal:  Anesthesiology       Date:  2003-10       Impact factor: 7.892

View more
  32 in total

1.  Diuretic, Natriuretic, and Vasodepressor Activity of a Lipid Fraction Enhanced in Medium of Cultured Mouse Medullary Interstitial Cells by a Selective Fatty Acid Amide Hydrolase Inhibitor.

Authors:  Zdravka Daneva; Sara K Dempsey; Ashfaq Ahmad; Ningjun Li; Pin-Lan Li; Joseph K Ritter
Journal:  J Pharmacol Exp Ther       Date:  2018-12-07       Impact factor: 4.030

2.  Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.

Authors:  M Bashashati; M A Storr; S P Nikas; J T Wood; G Godlewski; J Liu; W Ho; C M Keenan; H Zhang; S O Alapafuja; B F Cravatt; B Lutz; K Mackie; G Kunos; K D Patel; A Makriyannis; J S Davison; K A Sharkey
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.

Authors:  Sudeshna Ghosh; Laura E Wise; Yugang Chen; Ramesh Gujjar; Anu Mahadevan; Benjamin F Cravatt; Aron H Lichtman
Journal:  Life Sci       Date:  2012-06-28       Impact factor: 5.037

4.  The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.

Authors:  Jenny L Wilkerson; Sudeshna Ghosh; Mohammed Mustafa; Rehab A Abdullah; Micah J Niphakis; Roberto Cabrera; Rafael L Maldonado; Benjamin F Cravatt; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2016-11-25       Impact factor: 5.250

5.  CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin.

Authors:  Wei-Hsien Hou; I-Hua Liu; Cheng C Tsai; Frank E Johnson; Shuan Shian Huang; Jung San Huang
Journal:  J Cell Sci       Date:  2011-04-15       Impact factor: 5.285

6.  Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.

Authors:  Anushka V Goonawardena; John Sesay; Cheryl Ann Sexton; Gernot Riedel; Robert E Hampson
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

7.  Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues.

Authors:  Francesca M Filbey; Joseph P Schacht; Ursula S Myers; Robert S Chavez; Kent E Hutchison
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

Review 8.  Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.

Authors:  Joel E Schlosburg; Steven G Kinsey; Aron H Lichtman
Journal:  AAPS J       Date:  2009-01-29       Impact factor: 4.009

Review 9.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

10.  Mustard vesicants alter expression of the endocannabinoid system in mouse skin.

Authors:  Irene M Wohlman; Gabriella M Composto; Diane E Heck; Ned D Heindel; C Jeffrey Lacey; Christophe D Guillon; Robert P Casillas; Claire R Croutch; Donald R Gerecke; Debra L Laskin; Laurie B Joseph; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-26       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.